Back to search results

Sovateltide for Acute Ischemic Stroke

This study is looking at a drug called Sovateltide to see if it can help people who have had an acute ischemic stroke. An ischemic stroke happens when a blood clot blocks blood flow to part of the brain. Researchers want to find out if Sovateltide is safe and effective in improving recovery for patients. You might be able to join if you are between 18 and 80 years old and have had an acute ischemic stroke. The main goal is to see if participants have a good recovery, measured by their ability to do daily activities, 90 days after receiving the treatment.

Study design
This is an interventional study planning to enroll 514 participants. It compares Sovateltide to normal saline (a saltwater solution) to assess its effectiveness.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for 90 days after they are assigned to a treatment group.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT05691244

Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke

Recruiting
PHASE3Ages 18–80InterventionalTreatment
Pharmazz, Inc.
~514 participants
Updated 2026-09-15 on ClinicalTrials.gov
What's tested:Drug: Normal SalineSovateltide

At a glance

Recruiting sites
54 of 54 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Determine the efficacy of sovateltide in patients with acute cerebral ischemic stroke assessed by modified Rankin Scale (mRS) score of 0-2 at day 90 post-randomization.
Measured over Day 1 through Day 90

Conditions

Acute Ischemic Stroke
Cerebral Stroke

Explore related trials

Acute Ischemic Stroke

NCT05691244

Where you'd take part

This study runs at 54 sites. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Charite-Universitaetsmedizin Berlin

    Berlin, State of Berlin, Germanystudy coordinator listed

    Recruiting

  • Hackensack University Medical Center at Paramus

    Paramus, New Jerseystudy coordinator listed

    Recruiting

  • London North West University Healthcare NHS Trust - Northwick Park Hospital

    Harrow, United Kingdomstudy coordinator listed

    Recruiting

  • Medical Imbrain S.L.

    Melilla, Spainstudy coordinator listed

    Recruiting

  • Penn State Health Milton S. Hershey Medical Center

    Hershey, Pennsylvaniastudy coordinator listed

    Recruiting

  • RHON-KLINIKUM Campus Bad Neustadt

    Bad Neustadt an der Saale, Germanystudy coordinator listed

    Recruiting

  • Royal Stoke University Hospital

    Stoke-on-Trent, United Kingdomstudy coordinator listed

    Recruiting

  • St. George's University Hospitals

    London, London, United Kingdomstudy coordinator listed

    Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Study leadership

  • Anil Gulati, MD, PhD · STUDY_CHAIR · Pharmazz, Inc.

Who to contact

Anil Gulati, MD, PhD
[email protected]
6307806087
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

What this trial measures

  • Determine the efficacy of sovateltide in patients with acute cerebral ischemic stroke assessed by modified Rankin Scale (mRS) score of 0-2 at day 90 post-randomization.Day 1 through Day 90

    The proportion of acute cerebral ischemic stroke patients having a good functional outcome with a modified Rankin Scale score of 0-2 on day 90 post-randomization.